Novartis | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.29B 562M 2025-03
Alcon AG USD 813M 11M 2025-03
Almirall EUR 146.82M 1.94M 2024-12
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Autolus Therapeutics Ltd 29.53M 4.14M 2025-03
Bayer EUR 3.71B 628M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Fresenius EUR 643M 126M 2025-03
Fresenius Medical Care EUR 751M 89M 2025-03
Galapagos EUR 43.8M 2.55M 2025-03
Genmab DKK 126M 1.12B 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
GRIFOLS EUR 324.65M 55.17M 2025-03
Hikma Pharmaceutical USD 288M 8M 2024-12
J&J USD 5.89B 777M 2025-06
Merck EUR 1.47B 418M 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.44B 384M 2025-06
Novartis USD 3.5B 368M 2024-12
Novo Nordisk 16.11B 480M 2025-03
Orion EUR 96.7M 12.4M 2025-06
Pfizer USD 3.01B 1.27B 2025-03
Philips EUR 1.25B 77M 2025-03
Recordati EUR 181.39M 32.05M 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
UCB EUR 1.29B 221M 2024-12


Novartis Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Jul 2025.